{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:12:14Z","timestamp":1793686334111,"version":"4.5.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.amjmed.2026.04.041","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T23:20:14Z","timestamp":1778196014000},"page":"1435-1446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["From obesity to cardiovascular disease: pathological basis and clinical implications"],"prefix":"10.1016","volume":"139","author":[{"given":"Matteo","family":"Nardin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvin","family":"Kedhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Galasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Nardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Savonitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Condorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.amjmed.2026.04.041_bib0001","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s40273-014-0243-x","article-title":"The Epidemiology of Obesity: A Big Picture","volume":"33","author":"Hruby","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.amjmed.2026.04.041_bib0002","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10113","key":"10.1016\/j.amjmed.2026.04.041_bib0003","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","article-title":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults","volume":"390","year":"2017","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.amjmed.2026.04.041_bib0004","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"10.1016\/j.amjmed.2026.04.041_bib0005","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2337\/diabetes.52.7.1779","article-title":"Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression","volume":"52","author":"Kern","year":"2003","journal-title":"Diabetes"},{"issue":"6913","key":"10.1016\/j.amjmed.2026.04.041_bib0006","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature01137","article-title":"A central role for JNK in obesity and insulin resistance","volume":"420","author":"Hirosumi","year":"2002","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.amjmed.2026.04.041_bib0007","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjmed.2026.04.041_bib0008","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/978-3-031-63657-8_13","article-title":"Endoplasmic Reticulum Stress and Obesity","volume":"1460","author":"Yilmaz","year":"2024","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.amjmed.2026.04.041_bib0009","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/ATVBAHA.115.306263","article-title":"Uncoupling of Endothelial Nitric Oxide Synthase in Perivascular Adipose Tissue of Diet-Induced Obese Mice","volume":"36","author":"Xia","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/j.amjmed.2026.04.041_bib0010","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1113\/jphysiol.2011.221036","article-title":"Obesity and adipokines: effects on sympathetic overactivity","volume":"590","author":"Smith","year":"2012","journal-title":"J Physiol"},{"issue":"4","key":"10.1016\/j.amjmed.2026.04.041_bib0011","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.trsl.2014.05.001","article-title":"Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities","volume":"164","author":"Cavalera","year":"2014","journal-title":"Transl Res"},{"issue":"1","key":"10.1016\/j.amjmed.2026.04.041_bib0012","doi-asserted-by":"crossref","first-page":"7638","DOI":"10.1038\/s41467-024-52068-0","article-title":"Protein kinase N promotes cardiac fibrosis in heart failure by fibroblast-to-myofibroblast conversion","volume":"15","author":"Yoshida","year":"2024","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.amjmed.2026.04.041_bib0013","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1161\/01.ATV.0000242905.41404.68","article-title":"PAI-1 and the metabolic syndrome: links, causes, and consequences","volume":"26","author":"Alessi","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"20","key":"10.1016\/j.amjmed.2026.04.041_bib0014","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2013-05-427708","article-title":"Inflammation, obesity, and thrombosis","volume":"122","author":"Samad","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.amjmed.2026.04.041_bib0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41569-018-0097-6","article-title":"The role of adipose tissue in cardiovascular health and disease","volume":"16","author":"Oikonomou","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"10.1016\/j.amjmed.2026.04.041_bib0016","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1161\/ATVBAHA.120.312470","article-title":"Perivascular adipose tissue and vascular perturbation\/atherosclerosis","volume":"40","author":"Kim","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjmed.2026.04.041_bib0017","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fphys.2018.00253","article-title":"Perivascular adipose tissue as a relevant fat depot for cardiovascular risk in obesity","volume":"9","author":"Costa","year":"2018","journal-title":"Front Physiol"},{"issue":"21","key":"10.1016\/j.amjmed.2026.04.041_bib0018","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American heart association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.amjmed.2026.04.041_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12082883","article-title":"New insights into pathophysiology and new risk factors for ACS","volume":"12","author":"Nardin","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.amjmed.2026.04.041_bib0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and Inflammation in Atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.amjmed.2026.04.041_bib0021","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jacc.2022.12.021","article-title":"Pericoronary adipose tissue as a marker of cardiovascular risk: JACC review topic of the week","volume":"81","author":"Tan","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.amjmed.2026.04.041_bib0022","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1001\/archinte.167.16.1720","article-title":"Association of Overweight With Increased Risk of Coronary Heart Disease Partly Independent of Blood Pressure and Cholesterol Levels<subtitle>A Meta-analysis of 21 Cohort Studies Including More Than 300 000 Persons<\/subtitle>","volume":"167","author":"Bogers","year":"2007","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.amjmed.2026.04.041_bib0023","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jacc.2017.07.763","article-title":"Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women","volume":"70","author":"Caleyachetty","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2026.04.041_bib0024","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijcard.2021.11.080","article-title":"Association between obesity grade and the age of the first acute coronary syndrome: prospective observational study","volume":"351","author":"Demirci","year":"2022","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.amjmed.2026.04.041_bib0025","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jacc.2022.11.031","article-title":"Challenges in cardiovascular evaluation and management of obese patients: JACC state-of-the-art review","volume":"81","author":"Bianchettin","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.amjmed.2026.04.041_bib0026","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","article-title":"Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms","volume":"116","author":"Hall","year":"2015","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.amjmed.2026.04.041_bib0027","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40292-016-0137-4","article-title":"Sympathetic nervous system, hypertension, obesity and metabolic syndrome","volume":"23","author":"Seravalle","year":"2016","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"7","key":"10.1016\/j.amjmed.2026.04.041_bib0028","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/CIRCRESAHA.121.318061","article-title":"Arterial stiffness and cardiovascular risk in hypertension","volume":"128","author":"Boutouyrie","year":"2021","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.amjmed.2026.04.041_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20110151","article-title":"Perivascular adipose tissue: more than just structural support","volume":"122","author":"Szasz","year":"2012","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"10.1016\/j.amjmed.2026.04.041_bib0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1271","article-title":"Association of body mass index with blood pressure among 1.7 million chinese adults","volume":"1","author":"Linderman","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.amjmed.2026.04.041_bib0031","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jch.12049","article-title":"Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension","volume":"15","author":"Landsberg","year":"2013","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"5","key":"10.1016\/j.amjmed.2026.04.041_bib0032","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.HYP.0000094221.86888.AE","article-title":"Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials","volume":"42","author":"Neter","year":"2003","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.amjmed.2026.04.041_bib0033","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ahj.2007.10.004","article-title":"Atrial fibrillation and obesity\u2013results of a meta-analysis","volume":"155","author":"Wanahita","year":"2008","journal-title":"Am Heart J"},{"issue":"17","key":"10.1016\/j.amjmed.2026.04.041_bib0034","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.jacc.2010.11.045","article-title":"Pericardial fat is associated with atrial fibrillation severity and ablation outcome","volume":"57","author":"Wong","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.amjmed.2026.04.041_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2015.04.058","article-title":"Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity","volume":"66","author":"Mahajan","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.amjmed.2026.04.041_bib0036","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/CIRCEP.109.912055","article-title":"Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study","volume":"3","author":"Thanassoulis","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"6","key":"10.1016\/j.amjmed.2026.04.041_bib0037","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/jamacardio.2018.0095","article-title":"Associations of obstructive sleep apnea with atrial fibrillation and continuous positive airway pressure treatment: a review","volume":"3","author":"Linz","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"20","key":"10.1016\/j.amjmed.2026.04.041_bib0038","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.amjmed.2026.04.041_bib0039","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.amjmed.2026.04.041_bib0040","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.amjmed.2005.03.012","article-title":"Obesity as a risk factor in venous thromboembolism","volume":"118","author":"Stein","year":"2005","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.amjmed.2026.04.041_bib0041","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-0043-1772212","article-title":"The risk of incident venous thromboembolism attributed to overweight and obesity: the troms\u00f8 study","volume":"124","author":"Frischmuth","year":"2024","journal-title":"Thromb Haemost"},{"issue":"16","key":"10.1016\/j.amjmed.2026.04.041_bib0042","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1001\/archinte.159.16.1886","article-title":"Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: \u201cthe study of men born in 1913","volume":"159","author":"Hansson","year":"1999","journal-title":"Arch Intern Med"},{"issue":"9757","key":"10.1016\/j.amjmed.2026.04.041_bib0043","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/S0140-6736(10)60962-2","article-title":"Risk assessment for recurrent venous thrombosis","volume":"376","author":"Kyrle","year":"2010","journal-title":"The Lancet"},{"issue":"6","key":"10.1016\/j.amjmed.2026.04.041_bib0044","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.chest.2021.07.056","article-title":"Antithrombotic Therapy for VTE Disease: second update of the CHEST guideline and expert panel report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.amjmed.2026.04.041_bib0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.orcp.2024.11.006","article-title":"Obesity with low bone mineral density is a risk for cerebral small-vessel disease in older adults: The Bunkyo Health Study","volume":"18","author":"Ito","year":"2024","journal-title":"Obes Res Clin Pract"},{"issue":"10","key":"10.1016\/j.amjmed.2026.04.041_bib0046","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/archneur.62.10.1556","article-title":"Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease","volume":"62","author":"Kivipelto","year":"2005","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.amjmed.2026.04.041_bib0047","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ageing\/afv151","article-title":"The risk of overweight\/obesity in mid-life and late life for the development of dementia: a systematic review and meta-analysis of longitudinal studies","volume":"45","author":"Pedditzi","year":"2016","journal-title":"Age Ageing"},{"issue":"4","key":"10.1016\/j.amjmed.2026.04.041_bib0048","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11897-017-0337-9","article-title":"Inflammation - Cause or Consequence of Heart Failure or Both?","volume":"14","author":"Van Linthout","year":"2017","journal-title":"Curr Heart Fail Rep"},{"issue":"4","key":"10.1016\/j.amjmed.2026.04.041_bib0049","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.amjmed.2026.04.041_bib0050","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.tcm.2017.12.003","article-title":"Obesity and heart failure with preserved ejection fraction: A growing problem","volume":"28","author":"Prenner","year":"2018","journal-title":"Trends Cardiovasc Med"},{"issue":"12","key":"10.1016\/j.amjmed.2026.04.041_bib0051","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.amjmed.2026.04.041_bib0052","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.amjmed.2026.04.041_bib0053","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jacc.2024.11.001","article-title":"Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure: SUMMIT CMR Substudy","volume":"85","author":"Kramer","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.amjmed.2026.04.041_bib0054","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.amjmed.2026.04.041_bib0055","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10654-014-9961-9","article-title":"The obesity paradox in acute coronary syndrome: a meta-analysis","volume":"29","author":"Niedziela","year":"2014","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"10.1016\/j.amjmed.2026.04.041_bib0056","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrendo.2014.165","article-title":"Healthy obese versus unhealthy lean: the obesity paradox","volume":"11","author":"Lavie","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.amjmed.2026.04.041_bib0057","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/VHRM.S168946","article-title":"Obesity paradox in cardiovascular disease: where do we stand?","volume":"15","author":"Carbone","year":"2019","journal-title":"Vasc Health Risk Manag"},{"issue":"1","key":"10.1016\/j.amjmed.2026.04.041_bib0058","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ypmed.2013.03.010","article-title":"Body composition and fitness in the obesity paradox\u2014Body mass index alone does not tell the whole story","volume":"57","author":"Lavie","year":"2013","journal-title":"Prev Med (Baltim)"},{"issue":"3","key":"10.1016\/j.amjmed.2026.04.041_bib0059","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.mayocp.2013.11.011","article-title":"A pooled analysis of waist circumference and mortality in 650,000 adults","volume":"89","author":"Cerhan","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"10.1016\/j.amjmed.2026.04.041_bib0060","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/MCG.0000000000001916","article-title":"Summarizing consensus guidelines on obesity management","volume":"57","author":"Sharaiha","year":"2023","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.amjmed.2026.04.041_bib0061","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.soard.2016.12.018","article-title":"American society for metabolic and bariatric surgery integrated health nutritional guidelines for the surgical weight loss patient 2016 update: micronutrients","volume":"13","author":"Parrott","year":"2017","journal-title":"Surg Obesity Related Dis"},{"issue":"10390","key":"10.1016\/j.amjmed.2026.04.041_bib0062","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0140-6736(23)00634-7","article-title":"Bariatric\u2013metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial","volume":"401","author":"Verrastro","year":"2023","journal-title":"The Lancet"},{"issue":"16","key":"10.1016\/j.amjmed.2026.04.041_bib0063","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa2002449","article-title":"Life expectancy after bariatric surgery in the swedish obese subjects study","volume":"383","author":"Carlsson","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.amjmed.2026.04.041_bib0064","article-title":"Review on obesity management: bariatric surgery","volume":"2","author":"Peri","year":"2024","journal-title":"BMJ Public Health"},{"issue":"10350","key":"10.1016\/j.amjmed.2026.04.041_bib0065","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0140-6736(22)01280-6","article-title":"Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial","volume":"400","author":"Abu Dayyeh","year":"2022","journal-title":"The Lancet"},{"key":"10.1016\/j.amjmed.2026.04.041_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101882","article-title":"Pharmacotherapy of obesity: an update on the available medications and drugs under investigation","volume":"58","author":"Chakhtoura","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"12","key":"10.1016\/j.amjmed.2026.04.041_bib0067","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11936-024-01056-0","article-title":"Managing obesity in heart failure: latest evidence and knowledge gaps","volume":"26","author":"Ibrahim","year":"2024","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.amjmed.2026.04.041_bib0068","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41366-024-01473-y","article-title":"What is the pipeline for future medications for obesity?","volume":"49","author":"Melson","year":"2025","journal-title":"Int J Obes"},{"key":"10.1016\/j.amjmed.2026.04.041_bib0069","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231222367","article-title":"Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications","volume":"15","author":"Alharbi","year":"2024","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.amjmed.2026.04.041_bib0070","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.tcm.2024.03.003","article-title":"The cardiovascular effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: an anti-atherosclerotic action","volume":"34","author":"Alexiadou","year":"2024","journal-title":"Trends Cardiovasc Med"},{"issue":"Supplement_1","key":"10.1016\/j.amjmed.2026.04.041_bib0071","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.2337\/dc25-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20142025","volume":"48","author":"ElSayed","year":"2025","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.amjmed.2026.04.041_bib0072","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.amjmed.2026.04.041_bib0073","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"New Engl J Med"},{"key":"10.1016\/j.amjmed.2026.04.041_bib0074","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with semaglutide for the treatment of obesity","author":"Aronne","year":"2025","journal-title":"New Engl J Med"},{"issue":"6","key":"10.1016\/j.amjmed.2026.04.041_bib0075","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Triple-hormone-receptor agonist retatrutide for obesity - A Phase 2 Trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.amjmed.2026.04.041_bib0076","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/eurjpc\/zwae279","article-title":"Obesity and cardiovascular disease: an ESC clinical consensus statement","volume":"32","author":"Koskinas","year":"2025","journal-title":"Eur J Prev Cardiol"},{"issue":"10","key":"10.1016\/j.amjmed.2026.04.041_bib0077","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/s41366-021-00849-8","article-title":"Cost-effectiveness of bariatric surgery and non-surgical weight management programmes for adults with severe obesity: a decision analysis model","volume":"45","author":"Boyers","year":"2021","journal-title":"Int J Obes"},{"issue":"3","key":"10.1016\/j.amjmed.2026.04.041_bib0078","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2024.5586","article-title":"Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults","volume":"6","author":"Hwang","year":"2025","journal-title":"JAMA Health Forum"},{"issue":"8","key":"10.1016\/j.amjmed.2026.04.041_bib0079","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.14725","article-title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension","volume":"24","author":"Wilding","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.amjmed.2026.04.041_bib0080","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13929","article-title":"Discontinuing glucagon-like peptide-1 receptor agonists and body habitus: a systematic review and meta-analysis","author":"Berg","year":"2025","journal-title":"Obes Rev"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934326003827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934326003827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:13:18Z","timestamp":1790845998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934326003827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":80,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0002934326003827"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.04.041","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From obesity to cardiovascular disease: pathological basis and clinical implications","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.04.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}